Aetna is more likely to cover Mounjaro for people with a diagnosis of type 2 diabetes who have had an inadequate response or intolerance to metformin, who need combination therapy, and have an A1C of 7.5 percent or greater
Author contributions Michael A
Compounding Safety Context Compounded GLP-1 medications are not FDA-approved products
NICE accepted that it provides clinical benefit but considered the magnitude of benefit uncertain and the cost-effectiveness estimates too high for routine commissioning
This phenomenon, sometimes called metabolic overshoot, occurs because your body's appetite-regulating regions have been suppressed and suddenly release stored hunger signals when the medication withdraws
It also slows gastric emptying, meaning food remains in the stomach longer, which contributes to increased satiety and reduced calorie intake